Monday - Friday:
9:00am - 5:00pm (EST)
On the morning of Thursday - April 16, 2015 Representatives Danny K. Davis (D-IL) and Michael C. Burgess (R-TX) revealed the reintroduction of bipartisan legislation to renew the nation’s programs for research, surveillance, prevention, and treatment of Sickle Cell Disease (SCD).
We had a great turn out at our 1st Annual Walk with the Stars! We are excited to deliver a bigger and better event! This year SCDAA and member organizations across the country will be joining in a National Walk effort during the period of mid August through September! The SCDAA's very own 2nd Annual National Walk...
Our 43rd Annual Convention will take place September 23 - 26, 2015. Stay informed on all things convention related! Learn about this year's host hotel, events, announcements and abstract deadlines. Convention will be here before we know it!
The US Food and Drug Administration (FDA) has approved a new oral formulation of deferasirox. The tablet will be marketed as Jadenu by Novartis, who also market Exjade, which has been the standard deferasirox formulation for the past 10 years.